EX-99.1

Exhibit 1

AGREEMENT

The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.

Date: August 20, 2026



NAN FUNG GROUP HOLDINGS LIMITED

By:		/s/ Tang Chun Wai Nelson
		Name: Tang Chun Wai Nelson
		Title: Director

NF INVESTMENT HOLDINGS LIMITED

By:		/s/ Tang Chun Wai Nelson
		Name: Tang Chun Wai Nelson
		Title: Director

NAN FUNG LIFE SCIENCES HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director

NFLS PLATFORM HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director


PIVOTAL LIFE SCIENCES HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director



PIVOTAL PARTNERS LTD

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director


NFLS BETA LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director


PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD

By:		/s/ Peter Tuxen Bisgaard
		Name: Peter Tuxen Bisgaard
		Title: Director


PIVOTAL BIOVENTURE PARTNERS FUND II, L.P.

By:		PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD
		Its General Partner,

By:		/s/ Peter Tuxen Bisgaard
		Name: Peter Tuxen Bisgaard
		Title: Director


PERMWELL MANAGEMENT LIMITED

By:		/s/ Tang Chun Wai Nelson
		Name: Tang Chun Wai Nelson
		Title: Director